Wellington Management Group
STOK icon

Wellington Management Group’s Stoke Therapeutics STOK Stock Holding History

Wellington Management Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115M Buy
3,519,301
+423,601
+14% +$13.6M 0.02% 516
2026
Q1 		$101M Buy
3,095,700
+2,359,901
+321% +$77.4M 0.02% 548
2025
Q4 		$23.4M Sell
735,799
-1,954
-0.3% -$58.7K ﹤0.01% 975
2025
Q3 		$17.3M Buy
737,753
+600,687
+438% +$10.3M ﹤0.01% 1082
2025
Q2 		$1.56M Buy
137,066
+1,106
+0.8% +$10.5K ﹤0.01% 1632
2025
Q1 		$904K Buy
135,960
+1,148
+0.9% +$10.7K ﹤0.01% 1723
2024
Q4 		$1.49M Sell
134,812
-2,163
-2% -$26.6K ﹤0.01% 1644
2024
Q3 		$1.68M Sell
136,975
-6,661
-5% -$94.4K ﹤0.01% 1586
2024
Q2 		$1.94M Buy
143,636
+285
+0.2% +$3.85K ﹤0.01% 1519
2024
Q1 		$1.94M Buy
+143,351
New +$868K ﹤0.01% 1528
2023
Q4 		– Sell
-174,332
Closed -$687K – 1920
2023
Q3 		$687K Buy
174,332
+5,044
+3% +$33.2K ﹤0.01% 1656
2023
Q2 		$1.8M Sell
169,288
-31,609
-16% -$336K ﹤0.01% 1498
2023
Q1 		$1.67M Sell
200,897
-411,157
-67% -$3.71M ﹤0.01% 1544
2022
Q4 		$5.65M Sell
612,054
-651,345
-52% -$6.77M ﹤0.01% 1239
2022
Q3 		$16.2M Buy
1,263,399
+5,286
+0.4% +$84.2K ﹤0.01% 976
2022
Q2 		$16.6M Buy
1,258,113
+69,998
+6% +$1.06M ﹤0.01% 987
2022
Q1 		$25M Buy
+1,188,115
New +$23.8M ﹤0.01% 964
2020
Q4 		– Sell
-54,750
Closed -$1.83M – 2008
2020
Q3 		$1.83M Buy
54,750
+39,302
+254% +$1.12M ﹤0.01% 1428
2020
Q2 		$368K Sell
15,448
-115,732
-88% -$2.75M ﹤0.01% 1712
2020
Q1 		$3M Sell
131,180
-56,068
-30% -$1.39M ﹤0.01% 1296
2019
Q4 		$5.3M Buy
187,248
+42,325
+29% +$1.06M ﹤0.01% 1321
2019
Q3 		$3.12M Sell
144,923
-261,548
-64% -$7.29M ﹤0.01% 1460
2019
Q2 		$11.9M Buy
+406,471
New +$10.9M ﹤0.01% 1157

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group's STOK Position: Q2 2026 in Review

Wellington Management Group increased its Stoke Therapeutics (STOK) stake by 14% in Q2 2026, buying an estimated $13.6M and bringing the position to 3,519,301 shares worth $115M. The position accounts for 0.02% of the portfolio, ranked #516.

Wellington Management Group first reported a position in STOK in Q2 2019 and has held it in 23 quarters since. 198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Wellington Management Group held 3,519,301 shares of Stoke Therapeutics worth $115M as of Q2 2026.
  • Wellington Management Group bought 423,601 Stoke Therapeutics shares in Q2 2026, an estimated $13.6M.
  • Stoke Therapeutics made up 0.02% of Wellington Management Group's portfolio in Q2 2026, its #516 holding.
  • Wellington Management Group first reported a position in Stoke Therapeutics in Q2 2019 and has held it in 23 quarters since.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.